← Browse by Condition
Medical Condition

apnea of prematurity

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 4

ClinicalMetric tracks all active clinical trials for apnea of prematurity sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — apnea of prematurity Clinical Trials

How many clinical trials are currently recruiting for apnea of prematurity?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for apnea of prematurity, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for apnea of prematurity?
apnea of prematurity research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a apnea of prematurity clinical trial?
Eligibility criteria for apnea of prematurity trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 4
1
Top Sponsors
Semmelweis University 1 trial
McGill University Health Centre/Research Institute of the McGill University Health Centre 1 trial
NHS Greater Clyde and Glasgow 1 trial

Recruiting Clinical Trials

NCT06401083 Phase 4
Recruiting
The Effect of an Additional Pre-extubational Loading Dose of Caffeine-citrate
Enrollment
226 pts
Location
Hungary
Sponsor
Semmelweis University
View Trial →
NCT07732257
Recruiting
Wireless MicroPremVitals Button Sensor in the NICU
Enrollment
10 pts
Location
Canada
Sponsor
McGill University Health Centr...
View Trial →
NCT06292299
Recruiting
The PARS Study: Paediatric Advanced Respiratory Service Study - An Observational Diagnostic Feasibility Study
Enrollment
225 pts
Location
United Kingdom
Sponsor
NHS Greater Clyde and Glasgow
View Trial →

Related Conditions

premature birth (2) respiratory failure (1) fragility (1) bradycardia neonatal (1) sepses neonatal (1) sleep disordered breathing (1) respiratory rate (1) sudden unexpected death in epilepsy (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology